Back to search

Article

Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?

2018-05-25

Abstract excerpt

Recent changes in lung cancer care, including new approvals in first line and the introduction of high throughput molecular technologies in routine testing led us to question ourselves on how deeper molecular testing may be helpful for the optimal use of targeted drugs. In this article we review recent results in the scope of personalized medicine in lung cancer. We discuss biomarkers that have a therapeutic predi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0eb41a07-4460-5f32-9dd1-d9f79e3a1d31
DOI
10.20944/preprints201805.0357.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?DOI 10.20944/preprints201805.0357.v1
Select a neighboring publication to make it the new centre.